GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuso Pharmaceutical Industries Ltd (TSE:4538) » Definitions » Net Margin %

Fuso Pharmaceutical Industries (TSE:4538) Net Margin % : 3.31% (As of Dec. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Fuso Pharmaceutical Industries Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Fuso Pharmaceutical Industries's Net Income for the three months ended in Dec. 2023 was 円510 Mil. Fuso Pharmaceutical Industries's Revenue for the three months ended in Dec. 2023 was 円15,406 Mil. Therefore, Fuso Pharmaceutical Industries's net margin for the quarter that ended in Dec. 2023 was 3.31%.

The historical rank and industry rank for Fuso Pharmaceutical Industries's Net Margin % or its related term are showing as below:

TSE:4538' s Net Margin % Range Over the Past 10 Years
Min: 0.02   Med: 2.03   Max: 4.03
Current: 2.45


TSE:4538's Net Margin % is ranked worse than
53.39% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.53 vs TSE:4538: 2.45

Fuso Pharmaceutical Industries Net Margin % Historical Data

The historical data trend for Fuso Pharmaceutical Industries's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuso Pharmaceutical Industries Net Margin % Chart

Fuso Pharmaceutical Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.94 1.51 3.26 2.99 3.15

Fuso Pharmaceutical Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.43 0.95 3.55 1.71 3.31

Competitive Comparison of Fuso Pharmaceutical Industries's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Fuso Pharmaceutical Industries's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuso Pharmaceutical Industries's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuso Pharmaceutical Industries's Net Margin % distribution charts can be found below:

* The bar in red indicates where Fuso Pharmaceutical Industries's Net Margin % falls into.



Fuso Pharmaceutical Industries Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Fuso Pharmaceutical Industries's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin=Net Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=1605/51015
=3.15 %

Fuso Pharmaceutical Industries's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=510/15406
=3.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fuso Pharmaceutical Industries  (TSE:4538) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Fuso Pharmaceutical Industries Net Margin % Related Terms

Thank you for viewing the detailed overview of Fuso Pharmaceutical Industries's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuso Pharmaceutical Industries (TSE:4538) Business Description

Traded in Other Exchanges
N/A
Address
No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid.

Fuso Pharmaceutical Industries (TSE:4538) Headlines

No Headlines